These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26845135)

  • 1. Peroxisome Proliferator-Activated Receptors and their Ligands in Cancer Drug- Resistance: Opportunity or Challenge.
    Yousefi B; Zarghami N; Samadi N; Majidinia M
    Anticancer Agents Med Chem; 2016; 16(12):1541-1548. PubMed ID: 26845135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome Proliferator-Activated Receptor Ligands and Their Role in Chronic Myeloid Leukemia: Therapeutic Strategies.
    Yousefi B; Samadi N; Baradaran B; Shafiei-Irannejad V; Zarghami N
    Chem Biol Drug Des; 2016 Jul; 88(1):17-25. PubMed ID: 26841308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Anticancer Potential of Peroxisome Proliferator-Activated Receptor Antagonists.
    De Lellis L; Cimini A; Veschi S; Benedetti E; Amoroso R; Cama A; Ammazzalorso A
    ChemMedChem; 2018 Feb; 13(3):209-219. PubMed ID: 29276815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of peroxisome proliferator-activated receptor agonists on doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
    Yousefi B; Samadi N; Baradaran B; Rameshknia V; Shafiei-Irannejad V; Majidinia M; Targhaze N; Zarghami N
    Cell Mol Biol (Noisy-le-grand); 2015 Dec; 61(8):118-22. PubMed ID: 26718439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer.
    Sertznig P; Seifert M; Tilgen W; Reichrath J
    J Cell Physiol; 2007 Jul; 212(1):1-12. PubMed ID: 17443682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting peroxisome proliferator-activated receptors: a novel strategy for Philadelphia chromosome-positive leukemia cells.
    Okabe S; Tauchi T; Tanaka Y; Ohyashiki K
    Leuk Lymphoma; 2017 Nov; 58(11):2762-2764. PubMed ID: 28504032
    [No Abstract]   [Full Text] [Related]  

  • 7. Targeting peroxisome proliferator-activated receptors (PPARs): development of modulators.
    Pirat C; Farce A; Lebègue N; Renault N; Furman C; Millet R; Yous S; Speca S; Berthelot P; Desreumaux P; Chavatte P
    J Med Chem; 2012 May; 55(9):4027-61. PubMed ID: 22260081
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeted cancer therapy; nanotechnology approaches for overcoming drug resistance.
    Gao Y; Shen JK; Milane L; Hornicek FJ; Amiji MM; Duan Z
    Curr Med Chem; 2015; 22(11):1335-47. PubMed ID: 25666804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of PPAR activation in cancer therapeutic resistance: Implications for combination therapy and drug development.
    Zhang Y; Xiao B; Liu Y; Wu S; Xiang Q; Xiao Y; Zhao J; Yuan R; Xie K; Li L
    Eur J Pharmacol; 2024 Feb; 964():176304. PubMed ID: 38142851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptors: role of isoform gamma in the antineoplastic effect of iodine in mammary cancer.
    Nunez-Anita RE; Cajero-Juarez M; Aceves C
    Curr Cancer Drug Targets; 2011 Sep; 11(7):775-86. PubMed ID: 21762085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptors in regulation of cytochromes P450: new way to overcome multidrug resistance?
    Cizkova K; Konieczna A; Erdosova B; Lichnovska R; Ehrmann J
    J Biomed Biotechnol; 2012; 2012():656428. PubMed ID: 23193364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual screening of antitumour phytochemical against peroxisome proliferators activated receptor proteins PPARs.
    Riaz S; Ahmed M; Hasnain S
    Pak J Pharm Sci; 2020 Jan; 33(1(Supplementary)):379-383. PubMed ID: 32122871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptors and their relevance to dermatology.
    Friedmann PS; Cooper HL; Healy E
    Acta Derm Venereol; 2005; 85(3):194-202. PubMed ID: 16040401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics?
    Han S; Roman J
    Anticancer Drugs; 2007 Mar; 18(3):237-44. PubMed ID: 17264754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition.
    Avis I; Martínez A; Tauler J; Zudaire E; Mayburd A; Abu-Ghazaleh R; Ondrey F; Mulshine JL
    Cancer Res; 2005 May; 65(10):4181-90. PubMed ID: 15899809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research Progress in Reversal of Tumor Multi-drug Resistance via Natural Products.
    Guo Q; Cao H; Qi X; Li H; Ye P; Wang Z; Wang D; Sun M
    Anticancer Agents Med Chem; 2017 Nov; 17(11):1466-1476. PubMed ID: 29034843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinity-based separation methods for the study of biological interactions: The case of peroxisome proliferator-activated receptors in drug discovery.
    Temporini C; Brusotti G; Pochetti G; Massolini G; Calleri E
    Methods; 2018 Aug; 146():12-25. PubMed ID: 29462658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modulation of nuclear receptors on drug-metabolizing enzymes and transporters].
    Liu ZH; Li Y
    Yao Xue Xue Bao; 2012 Dec; 47(12):1575-81. PubMed ID: 23460960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update about the crucial role of stereochemistry on the effects of Peroxisome Proliferator-Activated Receptor ligands.
    Laghezza A; Piemontese L; Tortorella P; Loiodice F
    Eur J Med Chem; 2019 Aug; 176():326-342. PubMed ID: 31112893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer chemoresistance; biochemical and molecular aspects: a brief overview.
    Kachalaki S; Ebrahimi M; Mohamed Khosroshahi L; Mohammadinejad S; Baradaran B
    Eur J Pharm Sci; 2016 Jun; 89():20-30. PubMed ID: 27094906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.